Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture Results in Patients With Suspected Bloodstream Infection
Authors:
- Abderrahim OussalahAOAbderrahim Oussalah
- Janina FerrandJFJanina Ferrand
- Pierre Filhine-TresarrieuPFPierre Filhine-Tresarrieu
- Nejla AissaNANejla Aissa
- Isabelle Aimone-GastinIAIsabelle Aimone-Gastin
- Fares NamourFNFares Namour
- Matthieu GarciaMGMatthieu Garcia
- Alain LozniewskiALAlain Lozniewski
- Jean-Louis GuéantJGJean-Louis Guéant
Open Access
- 1 November 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (44) , e1774
Abstract
Previous studies have suggested that procalcitonin is a reliable marker for predicting bacteremia. However, these studies have had relatively small sample sizes or focused on a single clinical entity. The primary endpoint of this study was to investigate the diagnostic accuracy of procalcitonin for predicting or excluding clinically relevant pathogen categories in patients with suspected bloodstream infections. The secondary endpoint was to look for organisms significantly associated with internationally validated procalcitonin intervals. We performed a cross-sectional study that included 35,343 consecutive patients who underwent concomitant procalcitonin assays and blood cultures for suspected bloodstream infections. Biochemical and microbiological data were systematically collected in an electronic database and extracted for purposes of this study. Depending on blood culture results, patients were classified into 1 of the 5 following groups: negative blood culture, Gram-positive bacteremia, Gram-negative bacteremia, fungi, and potential contaminants found in blood cultures (PCBCs). The highest procalcitonin concentration was observed in patients with blood cultures growing Gram-negative bacteria (median 2.2 ng/mL [IQR 0.6-12.2]), and the lowest procalcitonin concentration was observed in patients with negative blood cultures (median 0.3 ng/mL [IQR 0.1-1.1]). With optimal thresholds ranging from ≤0.4 to ≤0.75 ng/mL, procalcitonin had a high diagnostic accuracy for excluding all pathogen categories with the following negative predictive values: Gram-negative bacteria (98.9%) (including enterobacteria [99.2%], nonfermenting Gram-negative bacilli [99.7%], and anaerobic bacteria [99.9%]), Gram-positive bacteria (98.4%), and fungi (99.6%). A procalcitonin concentration ≥10 ng/mL was associated with a high risk of Gram-negative (odds ratio 5.98; 95% CI, 5.20-6.88) or Gram-positive (odds ratio 3.64; 95% CI, 3.11-4.26) bacteremia but dramatically reduced the risk of PCBCs or fungemia. In this large real-life setting experience with more than 35,000 patients, procalcitonin was highly effective at excluding bloodstream infections regardless of pathogen categories. The results from our study are limited by its cross-sectional design and deserve to be validated in prospective longitudinal studies.Keywords
This publication has 43 references indexed in Scilit:
- Procalcitonin as an indicator of urosepsisResearch and Reports in Urology, 2013
- Procalcitonin Predicts Real-Time PCR Results in Blood Samples from Patients with Suspected SepsisPLOS ONE, 2012
- Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-AnalysisClinical Infectious Diseases, 2012
- Procalcitonin Algorithms for Antibiotic Therapy DecisionsArchives of internal medicine (1960), 2011
- Procalcitonin as a Marker for the Detection of Bacteremia and Sepsis in the Emergency DepartmentAmerican Journal of Clinical Pathology, 2011
- Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational studyCritical Care, 2010
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targetBritish Journal of Pharmacology, 2010
- Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZRespiratory Research, 2009
- Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteriaBMC Infectious Diseases, 2008